Ischemic and non-ischemic myocyte damage and antimyosin monoclonal imaging.


Antimyosin monoclonal antibody is a specific marker of impaired sarcolemmal integrity resulting not only from ischemia but also from non-ischemic myocardial injury, such as infection, inflammatory, or immunologic reactions, and alcohol or drug intoxication. In addition, antimyosin accumulation has been demonstrated in some forms of cardiomyopathy with… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.